申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP1739081A1
公开(公告)日:2007-01-03
A compound having an inhibitory activity against cysteine protease, represented by formula (I):
(wherein ring X is a heterocyclic group which may contain 1 to 4 hetero atoms selected from an nitrogen atom(s), a oxygen atom(s) and a sulfur atom(s) which may be oxidized, in addition to said nitrogen atom in the ring; J is a bond or a spacer having from 1 to 8 atoms; R, R1, R2 and R3 is each independently hydrogen atom or a substituent; n is 0 or an integer of 1 to 10), a salt thereof, a solvate thereof, or an N-oxide thereof, or a prodrug thereof; and an agent for prevention and/or treatment for a cysteine protease-related disease, such as osteoporosis, comprising it as an active ingredient are provided.
一种对半胱氨酸蛋白酶具有抑制活性的化合物,由式 (I) 表示:
(其中环 X 是杂环基团,除了环中的所述氮原子外,还可包含 1 至 4 个选自氮原子、氧原子和可被氧化的硫原子的杂原子;J 是具有 1 至 8 个原子的键或间隔物;R、R1、R2 和 R3 各自独立地是氢原子或取代基;n为0或1至10的整数)、其盐、其溶液或其N-氧化物或其原药;以及包含其作为活性成分的用于预防和/或治疗半胱氨酸蛋白酶相关疾病(如骨质疏松症)的制剂。